Ondansetron Hydrochloride 50 ml Syrup, 8 mg Tablet
Emeset 8 mg Tablet: Each film coated tablet contains Ondansetron 8 mg as Ondansetron hydrochloride USP.
Emeset 50 ml oral solution: Each 5 ml solution contains Ondansetron 4 mg as Ondansetron hydrochloride USP.
Emeset is used for:
• preventing nausea and vomiting caused by chemotherapy (in adults and children) or radiotherapy for cancer (adults only)
• preventing nausea and vomiting after surgery (adults only)
• preventing nausea and vomiting in pregnancy
To prevent chemotherapy induced nausea & vomiting (CINV):
Adult: The recommended adult oral dosage is 24 mg given as three 8 mg tablets in highly emetogenic chemotherapy. In case of moderately emetogenic chemotherapy the oral dose is one 8 mg tablet twice daily.
To prevent radiotherapy induced nausea & vomiting (RINV):
Adult: The recommended oral dosage is one 8 mg tablet given 3 times daily.
To prevent post operative nausea & vomiting (PONV):
Adult: The recommended dosage is 16 mg given as two 8 mg tablets 1 hour before induction of anesthesia.
To prevent nausea & vomiting in pregnancy: 8 mg tablet 2-3 times daily.
Dosage adjustment for patients with impaired hepatic function: The total daily dose of 8 mg should not be exceeded.